Newly released documents are raising explosive questions about what pharmaceutical insiders and America’s intelligence community knew about COVID-19 immunity during the earliest months of the pandemic and why Americans were hearing a dramatically different story in public.
Senator Rand Paul (R-KY) released records detailing a May 7, 2020, CIA briefing involving Dr. Scott Gottlieb, the former FDA commissioner who had joined Pfizer’s board of directors the previous year.
Paul announced on X:
“I released documents showing Pfizer and the CIA privately acknowledged high population immunity as early as May 2020, while the public heard a different story. Americans deserve the truth.”
He pointed to reporting at Brownstone Institute on a newly unclassified CIA meeting summary buried in the latest tranche of records Paul entered into the congressional record.
The date on the briefing is May 7, 2020.
That is two months after the country was shut down. Churches closed. Small businesses crushed. Kids locked out of school. Fauci and Deborah Birx still talking as if this was a rare, novel threat that required indefinite emergency rule until a pharmaceutical product arrived.
Inside the CIA, they were already talking seroprevalence. Seroprevalence is the percentage or proportion of people in a specific population who have antibodies against a specific disease or infectious agent in their blood serum.
Hellbound and Down 